Archive | Liberia

RSS feed for this section

Malaria Quarterly Updates July-September 2013

This report briefly describes the major activities that SIAPS carried out at the global level as well as in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Liberia, Mali, and South Sudan between July and September 2013.

Read full story · Comments are closed

Malaria Quarterly Updates January-March 2013

This report briefly describes the major activities that SIAPS carried out at the global level as well as in Angola, Burundi, the Democratic Republic of the Congo, Ethiopia, Guinea, Liberia, Mali, and South Sudan between January and March 2013.

Read full story · Comments are closed

Feasibility of Introducing ACTs and RDTs in Private Sector Pharmacies and Medicine Shops in Montserrado County, Liberia: A Qualitative Study

Liberia’s National Malaria Control Program (NMCP) requested that SIAPS undertake a study to explore the feasibility and willingness of private sector pharmacies and medicine shops in the Greater Monrovia and rural Montserrado areas of Montserrado County, Liberia, to perform RDTs and to select appropriate products to recommend for malaria treatment for customers to purchase.

Read full story · Comments are closed

Liberia

Malaria is endemic in Liberia and the entire population of approximately 3.5 million is at risk.  The recent Health Facility Survey (HFS) shows that malaria accounts for about 35% of outpatient department attendance and 33% of inpatient deaths. However due to the limited number of sufficiently staffed public health facilities, only 45% of the population […]

Read full story · Comments { 0 }

President’s Malaria Initiative: Private Sector Distribution of Artemisinin-Based Combination Therapies in Liberia

Download

In Liberia, it is estimated that at least 46% of the population accesses antimalarials through the private sector. Quality-assured ACTs, however, are generally more expensive than older antimalarials; therefore, the majority of these outlets still stock chloroquine and other monotherapies. According to the 2010–15 national malaria strategic plan, MOHSW is committed to increasing access to prompt and effective treatment.

Read full story · Comments are closed